Difference between revisions of "Reactive changes"
Jump to navigation
Jump to search
Line 21: | Line 21: | ||
**Nuclear enlargement. | **Nuclear enlargement. | ||
**Nuclear hyperchromasia. | **Nuclear hyperchromasia. | ||
**Prominent nucleoli. | **Prominent [[nucleoli]]. | ||
*Inflammation - any type (e.g. [[neutrophil|neutrophilic]], [[plasma cells|plasmacytic]], lymphoplasmacytic). | *Inflammation - any type (e.g. [[neutrophil|neutrophilic]], [[plasma cells|plasmacytic]], lymphoplasmacytic). | ||
Revision as of 07:12, 31 December 2014
- Reactive inflammatory changes and inflammatory changes redirect here.
Reactive changes is a commonly used term in pathology that implies:
- Inflammation.
- Nuclear changes compatible with inflammation.
General
Nuclear changes are seen in:
- Inflammatory processes.
- Repair.
- Neoplastic processes.
Significance of nuclear changes in inflammation:
- The line between a reactive process and a neoplastic process may be fuzzy, i.e. it may be very difficult to be certain whether something is benign or malignant.
Consequence:
- In the context of inflammation, nuclear changes are typically present and the threshold for calling suspicious or malignancy is typically higher.
Microscopic
Features - generic:
- Nuclear changes - typically:
- Nuclear enlargement.
- Nuclear hyperchromasia.
- Prominent nucleoli.
- Inflammation - any type (e.g. neutrophilic, plasmacytic, lymphoplasmacytic).
DDx:
- Waffle diagnosis (e.g. indefinite for dysplasia) - nuclear changes of unknown significance.
- Terminology dependent on the anatomical site.
- Nuclear atypia.
- This is often qualified as it may represent neoplastic process or a benign process dependent on the context.
- Common qualifiers:
- Worrisome lesions: "cannot exclude dysplasia", "suspicious for malignancy".
- Suspected to be benign: "favour benign".
- Malignancy.